MICHAEL E RYTTING to Drug Monitoring
This is a "connection" page, showing publications MICHAEL E RYTTING has written about Drug Monitoring.
Connection Strength
0.127
-
Asparaginase in acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk. 2014 Sep; 14 Suppl:S14-7.
Score: 0.101
-
A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia. Clin Cancer Res. 2015 Jun 15; 21(12):2704-14.
Score: 0.026